desoxycorticosterone has been researched along with cholecystokinin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreiling, DA; Tiscornia, OM | 1 |
| Lucas, LR; McEwen, BS; Ono, J; Pompei, P | 1 |
| Blackburn-Munro, RE; Roesch, DM; Verbalis, JG | 1 |
3 other study(ies) available for desoxycorticosterone and cholecystokinin
| Article | Year |
|---|---|
The effect of hypophysectomy on canine pancreatic function.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Amylases; Animals; Bicarbonates; Chlorides; Cholecystokinin; Desoxycorticosterone; Dexamethasone; Dogs; Hypophysectomy; Pancreas; Pituitary Gland; Potassium; Secretin; Sodium; Sodium Chloride | 1966 |
Effects of adrenal steroids on basal ganglia neuropeptide mRNA and tyrosine hydroxylase radioimmunoreactive levels in the adrenalectomized rat.
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Basal Ganglia; Cholecystokinin; Corticosterone; Desoxycorticosterone; Dynorphins; Enkephalins; Gene Expression; Male; Neuropeptides; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tachykinins; Tyrosine 3-Monooxygenase | 1998 |
Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II.
Topics: Angiotensin II; Animals; Cholecystokinin; Desoxycorticosterone; Drinking; Immunohistochemistry; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Sodium Chloride; Supraoptic Nucleus; Vasopressins | 2001 |